Similar articles

• Impact of 2017 ACC/AHA guidelines on prevalence of hypertension and eligibility for antihypertensive treatment in United States and China: nationally representative cross sectional study.

  Khera R, Lu Y, Lu J, Saxena A, Nasir K, Jiang L, Krumholz HM. Khera R, et al. BMJ. 2018 Jul 11;362:k2357. doi: 10.1136/bmj.k2357. BMJ. 2018. PMID: 29997129 Free PMC article.
• Baseline Blood Pressure, the 2017 ACC/AHA High Blood Pressure Guidelines, and Long-Term Cardiovascular Risk in SPRINT.

  Vaduganathan M, Pareek M, Qamar A, Pandey A, Olsen MH, Bhatt DL. Vaduganathan M, et al. Am J Med. 2018 Aug;131(8):956-960. doi: 10.1016/j.amjmed.2017.12.049. Epub 2018 Feb 5. Am J Med. 2018. PMID: 29421687 Clinical Trial.
• Long-Term Cardiovascular Risk Associated With Stage 1 Hypertension Defined by the 2017 ACC/AHA Hypertension Guideline.

  Qi Y, Han X, Zhao D, Wang W, Wang M, Sun J, Liu J, Li Y, Gao S, Hao Y, Deng Q, Liu J. Qi Y, et al. J Am Coll Cardiol. 2018 Sep 11;72(11):1201-1210. doi: 10.1016/j.jacc.2018.06.056. J Am Coll Cardiol. 2018. PMID: 30189996
• Increased Risk of Hypertension in Young Adults in Southwest China: Impact of the 2017 ACC/AHA High Blood Pressure Guideline.

  Li D, Zeng X, Huang Y, Lei H, Li G, Zhang N, Huang W. Li D, et al. Curr Hypertens Rep. 2019 Feb 28;21(3):21. doi: 10.1007/s11906-019-0926-y. Curr Hypertens Rep. 2019. PMID: 30820764 Review.
• ACC/AHA Versus ESC/ESH on Hypertension Guidelines: JACC Guideline Comparison.

  Bakris G, Ali W, Parati G. Bakris G, et al. J Am Coll Cardiol. 2019 Jun 18;73(23):3018-3026. doi: 10.1016/j.jacc.2019.03.507. J Am Coll Cardiol. 2019. PMID: 31196460 Review.